Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic and biological activities of berberine: The involvement of Nrf2 signaling pathway
Milad Ashrafizadeh, Hojjat Samareh Fekri, Zahra Ahmadi, et al.
Journal of Cellular Biochemistry (2019) Vol. 121, Iss. 2, pp. 1575-1585
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
Paul B. Tchounwou, Shaloam Dasari, Felicite K. Noubissi, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 303-328
Open Access | Times Cited: 272
In vivo gene delivery mediated by non-viral vectors for cancer therapy
Reza Mohammadinejad, Ali Dehshahri, Vijay Sagar Madamsetty, et al.
Journal of Controlled Release (2020) Vol. 325, pp. 249-275
Open Access | Times Cited: 201
Biological Activity of Berberine—A Summary Update
Anna Och, Rafał Podgórski, Renata Nowak
Toxins (2020) Vol. 12, Iss. 11, pp. 713-713
Open Access | Times Cited: 164
Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence
Xinmei Xu, Huan Yi, Jiasi Wu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110984-110984
Open Access | Times Cited: 162
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 119
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzielienė, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 5, pp. 1763-1790
Closed Access | Times Cited: 87
Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice
Xinlu Li, Jianfeng Chen, Wennuo Feng, et al.
Phytomedicine (2023) Vol. 118, pp. 154962-154962
Closed Access | Times Cited: 52
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 349-349
Open Access | Times Cited: 95
Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments
Robert Czarnomysy, Dominika Radomska, Olga Szewczyk‐Roszczenko, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8271-8271
Open Access | Times Cited: 84
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
Jean Bousquet, Jean‐Paul Cristol, Heather J. Zar, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways
Milad Ashrafizadeh, Hossein Rafiei, Reza Mohammadinejad, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 63
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Aranka Brockmueller, Saba Sameri, Alena Líšková, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 188-188
Open Access | Times Cited: 62
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression
Milad Ashrafizadeh, Navid Rabiee, Alan Prem Kumar, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2181-2198
Closed Access | Times Cited: 56
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 51
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Life Sciences (2022) Vol. 300, pp. 120561-120561
Closed Access | Times Cited: 49
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 40
Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
Mehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 5, pp. 166714-166714
Open Access | Times Cited: 32
Wenqingyin suppresses ferroptosis in the pathogenesis of sepsis-induced liver injury by activating the Nrf2-mediated signaling pathway
Lingpeng Xie, Chuying Zhou, Yuting Wu, et al.
Phytomedicine (2023) Vol. 114, pp. 154748-154748
Closed Access | Times Cited: 30
Effects of Berberine on Lipid Metabolism, Antioxidant Status, and Immune Response in Liver of Tilapia (Oreochromis niloticus) under a High-Fat Diet Feeding
Rui Jia, Yiran Hou, Liqiang Zhang, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 548-548
Open Access | Times Cited: 10
Neuroprotective effects of berberine in preclinical models of ischemic stroke: a systematic review
Ghasem Dolatkhah Laein, Elahe Boumeri, Saghar Ghanbari, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Functionalization of Polymers and Nanomaterials for Biomedical Applications: Antimicrobial Platforms and Drug Carriers
Masoud Delfi, Matineh Ghomi, Ali Zarrabi, et al.
Prosthesis (2020) Vol. 2, Iss. 2, pp. 117-139
Open Access | Times Cited: 60
A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
Yun Cai, Qiqi Xin, Jinjin Lu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 51
Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration
Kemal Uğur Tüfekçi, İlkcan Ercan, Kamer Burak Isci, et al.
Immunology Letters (2021) Vol. 233, pp. 20-30
Open Access | Times Cited: 43
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19
Jean Bousquet, Heather J. Zar, Torsten Zuberbier, et al.
International Archives of Allergy and Immunology (2021) Vol. 182, Iss. 4, pp. 324-338
Open Access | Times Cited: 41
Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions
Mahshid Deldar Abad Paskeh, Ava Asadi, Sepideh Mirzaei, et al.
Cellular Signalling (2022) Vol. 94, pp. 110323-110323
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top